Luteal phase GnRHa trigger in random start fertility preservation cycles

Journal of Assisted Reproduction and Genetics

Volumn 29, Issue 6, 2012, Pages 503-505

  Ozkaya, Enis ^a,b   Roman, Gabriel San ^b   Oktay, Kutluk ^a,b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Institute for Fertility Preservation and Reproductive Specialists of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANIRELIX; GONADORELIN DERIVATIVE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CASE REPORT; FEMALE; HODGKIN DISEASE; HUMAN; LUTEAL PHASE; OOCYTE RETRIEVAL; PRIORITY JOURNAL; REPRODUCTIVE PROCEDURE;

ADULT; FEMALE; FERTILITY PRESERVATION; GONADOTROPIN-RELEASING HORMONE; HODGKIN DISEASE; HUMANS; LUTEAL PHASE; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION;

EID: 84864920951     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-012-9752-8     Document Type: Article

References (5)

1. Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update. 2012;18(1):73-91.
2. Nayak SR, Wakim AN. Random-start gonadotropin-releasing hormone (GnRH) antagonist-treated cycles with GnRH agonist trigger for fertility preservation. Fertil Steril. 2011;96(1):e51-4.
3. Nilsson L, Andersen AN, Lindenberg S, Hausken J, Andersen CY, Kahn JA. Ganirelix for luteolysis in poor responder patients undergoing IVF treatment: a Scandinavian multicenter 'extended pilot study'. Acta Obstet Gynecol Scand. 2010;89(6):828-31.
4. Oktay K, Türkcüoǧlu I, Rodriguez-Wallberg KA. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod Biomed Online. 2010;20(6):783-8.
5. Sönmezer M, Türkcüoǧlu I, Co?kun U, Oktay K. Random-start controlled ovarian hyperstimulation for emergency fertilitypreservation in letrozole cycles. Fertil Steril. 2011;95(6):2125.e9- 2125.e11.